Blend Labs, Inc. (NYSE:BLND – Get Free Report) insider Nima Ghamsari sold 311,886 shares of the business’s stock in a transaction on Thursday, August 14th. The stock was sold at an average price of $2.90, for a total transaction of $904,469.40. Following the completion of the transaction, the insider directly owned 5,754,051 shares in the company, valued at $16,686,747.90. This trade represents a 5.14% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link.
Nima Ghamsari also recently made the following trade(s):
- On Friday, June 13th, Nima Ghamsari sold 75,720 shares of Blend Labs stock. The stock was sold at an average price of $3.30, for a total transaction of $249,876.00.
- On Thursday, June 12th, Nima Ghamsari sold 44,130 shares of Blend Labs stock. The stock was sold at an average price of $3.52, for a total transaction of $155,337.60.
Blend Labs Stock Performance
BLND stock opened at $2.9850 on Thursday. Blend Labs, Inc. has a one year low of $2.63 and a one year high of $5.53. The company’s fifty day moving average price is $3.34 and its 200-day moving average price is $3.44. The company has a market capitalization of $775.09 million, a PE ratio of -19.90 and a beta of 1.24.
Wall Street Analyst Weigh In
BLND has been the topic of a number of recent research reports. Canaccord Genuity Group reaffirmed a “buy” rating and set a $5.25 price target on shares of Blend Labs in a research note on Monday, May 12th. Keefe, Bruyette & Woods decreased their price target on shares of Blend Labs from $4.00 to $3.75 and set a “market perform” rating on the stock in a research note on Friday, August 8th. The Goldman Sachs Group decreased their price target on shares of Blend Labs from $5.60 to $4.80 and set a “buy” rating on the stock in a research note on Monday, May 12th. UBS Group decreased their price target on shares of Blend Labs from $4.00 to $3.50 and set a “neutral” rating on the stock in a research note on Friday, August 8th. Finally, JMP Securities reaffirmed a “market outperform” rating and set a $7.00 price target on shares of Blend Labs in a research note on Wednesday, May 28th. One equities research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $4.88.
Check Out Our Latest Stock Analysis on Blend Labs
Hedge Funds Weigh In On Blend Labs
Several hedge funds have recently added to or reduced their stakes in the company. Lightspeed Management Company L.L.C. bought a new position in Blend Labs during the 4th quarter valued at about $97,366,000. Vanguard Group Inc. grew its holdings in Blend Labs by 4.6% during the 1st quarter. Vanguard Group Inc. now owns 17,586,601 shares of the company’s stock valued at $58,915,000 after purchasing an additional 775,091 shares during the last quarter. Metavasi Capital LP grew its holdings in Blend Labs by 15.6% during the 1st quarter. Metavasi Capital LP now owns 5,554,101 shares of the company’s stock valued at $18,606,000 after purchasing an additional 750,000 shares during the last quarter. Whitebark Investors LP grew its holdings in Blend Labs by 4.6% during the 2nd quarter. Whitebark Investors LP now owns 4,853,883 shares of the company’s stock valued at $16,018,000 after purchasing an additional 214,609 shares during the last quarter. Finally, Geode Capital Management LLC grew its holdings in Blend Labs by 1.6% during the 4th quarter. Geode Capital Management LLC now owns 4,842,483 shares of the company’s stock valued at $20,391,000 after purchasing an additional 75,379 shares during the last quarter. 52.56% of the stock is currently owned by institutional investors.
Blend Labs Company Profile
Blend Labs, Inc engages in the provision of cloud-based software platform solutions for financial services firms in the United States. It operates in two segments, Blend Platform and Title365. The company's Blend Builder Platform offers a suite of products that powers digital-first consumer journeys for mortgages, home equity loans and lines of credit, vehicle loans, personal loans, credit cards, and deposit accounts; and offers mortgage products to facilitate the homeownership journey for consumers comprising close, income verification for mortgage, homeowners' insurance, and realty.
Recommended Stories
- Five stocks we like better than Blend Labs
- How to Capture the Benefits of Dividend Increases
- Lowe’s Builds Value for Investors: Still a Good Buy in 2025
- Short Selling – The Pros and Cons
- Jackson Hole 2025: Fed’s Signal Could Shift Stocks Fast
- Compound Interest and Why It Matters When Investing
- Rocket Lab Stock: Breakout Brewing or Time for Patience?
Receive News & Ratings for Blend Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Blend Labs and related companies with MarketBeat.com's FREE daily email newsletter.